Mar 25, 2026 04:18PM

Feb 5, 2026 07:02AM

Feb 5, 2026 07:00AM

Jan 21, 2026 07:01AM

Jan 21, 2026 07:00AM

Dec 8, 2025 04:30PM

Dec 8, 2025 04:30PM Exicure Presents Positive Topline Phase 2 Data for Burixafor in Multiple Myeloma at 2025 ASH Annual Meeting

Nov 7, 2025 04:00PM

Nov 3, 2025 09:00AM

Oct 6, 2025 07:01AM

Oct 6, 2025 07:00AM

Aug 8, 2025 04:01PM

Aug 1, 2025 04:01PM

Aug 1, 2025 04:01PM Exicure Completes the Last Patient, Last Visit in Phase 2 Study of GPC-100 for Stem Cell Mobilization in Multiple Myeloma Patients Undergoing Autologous Transplant

Jun 27, 2025 04:01PM

May 5, 2025 08:00AM

Jan 22, 2025 04:02PM

Jan 22, 2025 04:01PM

Jan 22, 2025 04:01PM

Dec 26, 2024 08:08PM

Dec 20, 2024 04:42PM Exicure, Inc. Announces Shareholders Approve the $8.7 Million Equity Financing and Reports Executive Management and Board Changes

Dec 20, 2024 04:42PM

Aug 2, 2021 09:31AM

Dec 19, 2019 09:30AM

1,160,146 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All